Extentus Pharma Ltd
08949503
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
secretary · Since 17/04/2014
director · Since 19/04/2019
DIRECTOR
BRITISH · ENGLAND · Age 64
Also on 2 other boards
director · Since 01/08/2024
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 54
Also on 7 other boards
Persons with Significant Control
University Of Liverpool
765, Brownlow Hill, Liverpool, L69 7ZX
Notified 06/04/2016
CompanyRankvs 25210+ SIC 72110 peers42
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2025
Net Worth
-£1.3M
Balance sheet strength
Cash
£200k
Cash in the bank
Net Current Assets
-£678k
Working capital
Current Assets
£224k
Current Liabilities
£902k
Debtors
£24k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.25 | -£55k |
| 2024 | 0.29 | -£268k |
| 2023 | 0.39 | +£3k |
| 2022 | 0.39 | -£381k |
| 2021 | 1.10 | -£146k |
| 2020 | 3.76 | -£285k |
| 2019 | 6.26 | — |
Derived from filed accounts. Not audited figures.